Mohanad Nada, Associate Professor of Pathology/Hematology, Medical & Health Sciences (MHS) Department Chair | The American University of Iraq Sulaimani

Warning message

Mean Menu style requires jQuery library version 1.7 or higher, but you have opted to provide your own library. Please ensure you have the proper version of jQuery included. (note: this is not an error)

Mohanad Nada, Associate Professor of Pathology/Hematology, Medical & Health Sciences (MHS) Department Chair

Department of Medical & Health Sciences (MHS)
 
 
Office: B-F2-17
 
 
 
 
 
Dr. Mohanad Nada, or Dr. Mo as he likes to be called, is a medical specialist in immunopathology. He has completed extensive training and research in the field of Onco-immunology and pathology in the U.S. and other countries. He obtained his Ph.D. from Carver College of Medicine at the University of Iowa along with a Graduate Diploma in Public Health with special focus on cancer prevention. Before joining AUIS, Dr. Mo worked as a postdoctoral fellow in the Department of Internal Medicine at the University of Iowa Hospital and Clinics UIHC. He has more than six years of active academic teaching experience in American and Iraqi medical schools. Dr. Mo has recently gained the full membership in the European Society of Medical Oncology (ESMO). Also, he was selected as an Obermann Graduate Institute for Advance Studies fellow. Dr. Mo is an active member of several professional organizations, including the American Association of Cancer Research (AACR), American Association of Immunologists (AAI), and the Society of Immunotherapy for Cancer (SITC). 
 
Dr. Mo is an active medical researcher through collaborations with medical researchers in the U.S. and Europe. His research focuses on tumor immunology and immunotherapy, aiming to develop new approaches to cure cancer using the body's own immune system. His research has been published in high-impact journals in the U.S. and Europe. In 2019, Dr. Mo won the Munich Cancer Center Award for best-presented paper in the ITOC 06 conference in Vienna. One of his papers has been published in JITC with an impact factor of 8.40.
 
Dr. Mo is open for collaborations with other physicians and researchers who are interested in his field. 
 
 

PUBLICATIONS